Role of traditional Chinese medicine in bone regeneration and osteoporosis

Z Peng, R Xu, Q You - Frontiers in Bioengineering and Biotechnology, 2022 - frontiersin.org
According to World Health Organization (WHO), osteoporosis is a systematic bone disability
marked by reduced bone mass and microarchitectural degeneration of osseous cells, which …

[PDF][PDF] Pharmacological agents and natural compounds: available treatments for osteoporosis.

M Martiniakova, M Babikova, R Omelka - Journal of Physiology & …, 2020 - jpp.krakow.pl
Osteoporosis, a systemic skeletal disease characterized by a decrease in bone mass and
deterioration of bone structure leading to an increased risk of fragility fractures, represents …

Therapeutic anabolic and anticatabolic benefits of natural Chinese medicines for the treatment of osteoporosis

J He, X Li, Z Wang, S Bennett, K Chen, Z Xiao… - Frontiers in …, 2019 - frontiersin.org
Osteoporosis is a bone disease characterized by increasing osseous fragility and fracture
due to the reduced bone mass and microstructural degradation. Primary pharmacological …

Mitigating osteonecrosis of the jaw (ONJ) through preventive dental care and understanding of risk factors

JT Wan, DM Sheeley, MJ Somerman, JS Lee - Bone research, 2020 - nature.com
It is well established that alterations in phosphate metabolism have a profound effect on
hard and soft tissues of the oral cavity. The present-day clinical form of osteonecrosis of the …

Post-operative endodontic pain management: An overview of systematic reviews on post-operatively administered oral medications and integrated evidence-based …

F Di Spirito, G Scelza, R Fornara, F Giordano, D Rosa… - Healthcare, 2022 - mdpi.com
Endodontic treatment comprises the overall management of pre-, intra-and post-operative
symptoms, including post-operative endodontic pain, considered as a complication …

Risk factors for bisphosphonate-associated osteonecrosis of the jaw in the prospective randomized trial of adjuvant bisphosphonates for early-stage breast cancer …

DA Kizub, J Miao, MM Schubert, AHG Paterson… - Supportive Care in …, 2021 - Springer
Purpose Bisphosphonates reduce bone metastases in postmenopausal women with early-
stage breast cancer but carry the risk of bisphosphonate-related osteonecrosis of the jaw …

Gamabufotalin inhibits osteoclastgenesis and counteracts estrogen-deficient bone loss in mice by suppressing RANKL-induced NF-κB and ERK/MAPK pathways

K Sun, J Zhu, Y Deng, X Xu, F Kong, X Sun… - Frontiers in …, 2021 - frontiersin.org
Osteolytic bone disease is a condition of imbalanced bone homeostasis, characterized
mainly by excessive bone-resorptive activity, which could predispose these populations …

In vitro screening studies on eight commercial essential oils-derived compounds to identify promising natural agents for the prevention of osteoporosis

M Trzaskowska, V Vivcharenko, P Kazimierczak… - Biomedicines, 2023 - mdpi.com
Over the years, essential oils (EOs) and their compounds have gained growing interest due
to their anti-inflammatory, antimicrobial, antioxidant, and immunomodulatory properties. The …

[HTML][HTML] Suppression of high bone remodelling by E'Jiao in ovariectomised rats

SO Ekeuku, KY Chin, J Qian, Y Zhang, H Qu… - Biomedicine & …, 2022 - Elsevier
The current prevention options for postmenopausal osteoporosis are very limited. E'Jiao is a
collagen-rich traditional Chinese medicine with the potential to prevent osteoporosis but …

[PDF][PDF] Biphosphonates related osteonecrosis of the jaw in cancer patients—Epidemiological study

GA Ciobanu, A Camen, M Ionescu, D Vlad, V Mercut… - Rom. J. Oral Rehabil, 2022 - rjor.ro
Aim of the study Medication related osteonecrosis of the jaw (MRONJ) is a severe drug
adverse effect, often being diagnosed in an advanced stage. The aim of this epidemiological …